A review on synthetic chalcone derivatives as tubulin polymerisation inhibitors

References

• Kaur R, Kaur G, Gill RK, et al. Recent developments in tubulin polymerization inhibitors: an overview. Eur J Med Chem 2014;87:89–124.
   PubMed Web of Science ®Google Scholar
• Peerzada MN, Hamel E, Bai R, et al. Deciphering the key heterocyclic scaffolds in targeting microtubules, kinases and carbonic anhydrases for cancer drug development. Pharmacol Ther 2021;225:107860.
   PubMed Web of Science ®Google Scholar
• Jordan A, Hadfield J, Lawrence J, et al. Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle. MRR 1998;18:259–96.
   PubMed Web of Science ®Google Scholar
• Sorger PK, Dobles M, Tournebize R, Hyman AA. Coupling cell division and cell death to microtubule dynamics. Curr Opin Cell Biol 1997;9:807–14.
   PubMed Web of Science ®Google Scholar
• Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer 2004;4:253–65.
   PubMed Web of Science ®Google Scholar
• Menezes C. Arylidene indanone scaffold: medicinal chemistry and structure–activity relationship view. RSC Adv 2017;7:9357–72.
   Web of Science ®Google Scholar
• Risinger AL, Giles FJ, Mooberry SL. Microtubule dynamics as a target in oncology. Cancer Treat Rev 2009;35:255–61.
   PubMed Web of Science ®Google Scholar
• Li L, Jiang S, Li X, et al. Recent advances in trimethoxyphenyl (tmp) based tubulin inhibitors targeting the colchicine binding site. Euro J Med Chem 2018;151:482–94.
   PubMed Web of Science ®Google Scholar
• Pellegrini F, Budman DR. Review: tubulin function, action of antitubulin drugs, and new drug development. Cancer Invest 2005;23:264–73.
   PubMed Web of Science ®Google Scholar
• Haider K, Rahaman S, Yar MS, Kamal A. Tubulin inhibitors as novel anticancer agents: an overview on patents (2013-2018). Expert Opin Ther Pat 2019;29:623–41.
   PubMed Web of Science ®Google Scholar
• Cheng ZQ, Lu X, Feng BM. A review of research progress of antitumor drugs based on tubulin targets. Transl Cancer Res 2020;9:4020–7.
   PubMed Web of Science ®Google Scholar
• Jandial DD, Blair CA, Zhang S, et al. Molecular targeted approaches to cancer therapy and prevention using chalcones. Curr Cancer Drug Targets 2014;14:181–200.
   PubMed Web of Science ®Google Scholar
• Xu M, Wu PY, Shen F, et al. Chalcone derivatives and their antibacterial activities: current development. Bioorg Chem 2019;91:103133.
   PubMed Web of Science ®Google Scholar
• Qin HL, Zhang ZW, Lekkala R, et al. Chalcone hybrids as privileged scaffolds in antimalarial drug discovery: a key review. Eur J Med Chem 2020;193:112215.
   PubMed Web of Science ®Google Scholar
• Thapa P, Upadhyay SP, Suo WLZ, et al. Chalcone and its analogs: therapeutic and diagnostic applications in alzheimer's disease. Bioorg Chem 2021;108:104681.
   PubMed Web of Science ®Google Scholar
• Edwards ML, Stemerick DM, Sunkara PS. Chalcones: a new class of antimitotic agents. J Med Chem 1990;33:1948–54.
   PubMed Web of Science ®Google Scholar
• Xiao JQ, Gao MX, Diao Q, et al. Chalcone derivatives and their activities against drug-resistant cancers: an overview. Curr Top Med Chem 2021;21:348–62.
   PubMed Web of Science ®Google Scholar
• Lawrence NJ, McGown AT, Ducki S, et al. The interaction of chalcones with tubulin. Anti Cancer Drug Design 2000;15:135–41.
   PubMedGoogle Scholar
• Tu HY, Huang AM, Hour TC, et al. Synthesis and biological evaluation of 2',5'-dimethoxychalcone derivatives as microtubule-targeted anticancer agents. Bioorg Med Chem 2010;18:2089–98.
   PubMed Web of Science ®Google Scholar
• Kong Y, Wang K, Edler MC, et al. A boronic acid chalcone analog of combretastatin a-4 as a potent anti-proliferation agent. Bioorg Med Chem 2010;18:971–7.
   PubMed Web of Science ®Google Scholar
• Salum LB, Altei WF, Chiaradia LD, et al. Cytotoxic 3,4,5-trimethoxychalcones as mitotic arresters and cell migration inhibitors. Euro J Med Chem 2013;63:501–10.
   PubMed Web of Science ®Google Scholar
• Tajuddin Y, Harun Z, Ghazali AR, et al. Synthesis of chalcone derivatives and their effects on proliferation and tubulin dynamics instability of ht-29 cells. Letters in Drug Design 2016;13:662–7.
   Web of Science ®Google Scholar
• Aryapour H, Riazi GH, Foroumadi A, et al. Biological evaluation of synthetic analogues of curcumin: chloro-substituted-2′-hydroxychalcones as potential inhibitors of tubulin polymerization and cell proliferation. Med Chem Res 2011;20:503–10.
   Web of Science ®Google Scholar
• Burmaoglu S, Aktas Anil D, Gobek A, et al. Design, synthesis and antiproliferative activity evaluation of fluorine-containing chalcone derivatives. J Biomol Struct Dyn 2020. DOI: 10.1080/07391102.2020.1848627
   Google Scholar
• Abosalim HM, Nael MA, El‐Moselhy TF. Design, synthesis and molecular docking of chalcone derivatives as potential anticancer agents. Chem Select 2021;6:888–95.
   Google Scholar
• Ye H, Fu A, Wu W, et al. Cytotoxic and apoptotic effects of constituents from millettia pachycarpa benth. Fitoterapia 2012;83:1402–8.
   PubMed Web of Science ®Google Scholar
• Wu W, Ye H, Wan L, et al. Millepachine, a novel chalcone, induces g2/m arrest by inhibiting cdk1 activity and causing apoptosis via ros-mitochondrial apoptotic pathway in human hepatocarcinoma cells in vitro and in vivo. Carcinogenesis 2013;34:1636–43.
   PubMed Web of Science ®Google Scholar
• Wang G, Wu W, Peng F, et al. Design, synthesis, and structure-activity relationship studies of novel millepachine derivatives as potent antiproliferative agents. Eur J Med Chem 2012;54:793–803.
   PubMed Web of Science ®Google Scholar
• Wang G, Peng F, Cao D, et al. Design, synthesis and biological evaluation of millepachine derivatives as a new class of tubulin polymerization inhibitors. Bioorg Med Chem 2013;21:6844–54.
   PubMedGoogle Scholar
• Wang G, Li C, He L, et al. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents. Bioorg Med Chem 2014;22:2060–79.
   PubMed Web of Science ®Google Scholar
• Yang Z, Wu W, Wang J, et al. Synthesis and biological evaluation of novel millepachine derivatives as a new class of tubulin polymerization inhibitors. J Med Chem 2014;57:7977–89.
   PubMed Web of Science ®Google Scholar
• Yang J, Yan W, Yu Y, et al. The compound millepachine and its derivatives inhibit tubulin polymerization by irreversibly binding to the colchicine-binding site in β-tubulin. J Biol Chem 2018;293:9461–72.
   PubMed Web of Science ®Google Scholar
• Cao D, Han X, Wang G, et al. Synthesis and biological evaluation of novel pyranochalcone derivatives as a new class of microtubule stabilizing agents. Euro J Med Chem 2013;62:579–89.
   PubMed Web of Science ®Google Scholar
• Milelli A, Tumiatti V, Micco M, et al. Structure-activity relationships of novel substituted naphthalene diimides as anticancer agents. Euro J Med Chem 2012;57:417–28.
   PubMed Web of Science ®Google Scholar
• Sharma S, Singh T, Mittal R, et al. A study of anti-inflammatory activity of some novel alpha-amino naphthalene and beta-amino naphthalene derivatives. Archiv Der Pharmazie 2006;339:145–52.
   PubMed Web of Science ®Google Scholar
• Ateş-Alagöz Z, Kuş C, Coban T. Synthesis and antioxidant properties of novel benzimidazoles containing substituted indole or 1,1,4,4-tetramethyl-1,2,3,4-tetrahydro-naphthalene fragments. Journal of Enzyme Inhibition and Medicinal Chemistry 2005;20:325–31.
   PubMed Web of Science ®Google Scholar
• Altintop MD, Atli O, Ilgin S. Synthesis and biological evaluation of new naphthalene substituted thiosemicarbazone derivatives as potent antifungal and anticancer agents. Euro J Med Chem 2016;108:406–14.
   PubMed Web of Science ®Google Scholar
• Voskiene A, Sapijanskaite B, Mickevicius V, et al. Synthesis and microbiological evaluation of new 2- and 2,3-diphenoxysubstituted naphthalene-1,4-diones with 5-oxopyrrolidine moieties. Molecules 2012;17:14434–48.
   PubMed Web of Science ®Google Scholar
• Lee JM, Lee MS, Koh D, et al. A new synthetic 2'-hydroxy-2,4,6-trimethoxy-5',6'-naphthochalcone induces g2/m cell cycle arrest and apoptosis by disrupting the microtubular network of human colon cancer cells. Cancer Lett 2014;354:348–54.
   PubMed Web of Science ®Google Scholar
• Shin SY, Kim JH, Yoon H, et al. Novel antimitotic activity of 2-hydroxy-4-methoxy-2',3'-benzochalcone (hymnpro) through the inhibition of tubulin polymerization. J Agric Food Chem 2013;61:12588–97.
   PubMed Web of Science ®Google Scholar
• Lee K, Lee DH, Kim J-H, et al. The chalcone derivative hymnpro generates reactive oxygen species through depletion of intracellular glutathione. Appl Biol Chem 2016;59:391–6.
   Web of Science ®Google Scholar
• Wang G, Liu W, Gong Z, et al. Synthesis, biological evaluation, and molecular modelling of new naphthalene-chalcone derivatives as potential anticancer agents on mcf-7 breast cancer cells by targeting tubulin colchicine binding site. J Enzyme Inhibition Med Chem 2020;35:139–44.
   PubMed Web of Science ®Google Scholar
• Wang G, Qiu J, Xiao X, et al. Synthesis, biological evaluation and molecular docking studies of a new series of chalcones containing naphthalene moiety as anticancer agents. Bioorg Chem 2018;76:249–57.
   PubMed Web of Science ®Google Scholar
• dos Santos EA, Hamel E, Bai R, et al. Synthesis and evaluation of diaryl sulfides and diaryl selenide compounds for antitubulin and cytotoxic activity. Bioorg Med Chem Lett 2013;23:4669–73.
   PubMed Web of Science ®Google Scholar
• Xu Q, Sun M, Bai Z, et al. Design, synthesis and bioevaluation of antitubulin agents carrying diaryl-5,5-fused-heterocycle scaffold. Eur J Med Chem 2017;139:242–9.
   PubMed Web of Science ®Google Scholar
• Wu-Wong JR, Alder JD, Alder L, et al. Identification and characterization of a-105972, an antineoplastic agent. Cancer Res 2001;61:1486–92.
   PubMed Web of Science ®Google Scholar
• Cao D, Liu Y, Yan W, et al. Design, synthesis, and evaluation of in vitro and in vivo anticancer activity of 4-substituted coumarins: a novel class of potent tubulin polymerization inhibitors. J Med Chem 2016;59:5721–39.
   PubMed Web of Science ®Google Scholar
• Wang G, Peng Z, Zhang J, et al. Synthesis, biological evaluation and molecular docking studies of aminochalcone derivatives as potential anticancer agents by targeting tubulin colchicine binding site. Bioorg Chem 2018;78:332–40.
   PubMed Web of Science ®Google Scholar
• Kossakowski J, Ostrowska K, Hejchman E, et al. Synthesis and structural characterization of derivatives of 2- and 3-benzo[b]furan carboxylic acids with potential cytotoxic activity. Farmaco 2005;60:519–27.
   PubMedGoogle Scholar
• Hwang JW, Choi DH, Jeon JH, et al. Facile preparation of 2-arylbenzo[b]furan molecules and their anti-inflammatory effects. Bull Korean Chem Soc 2010;31:965–70.
   Web of Science ®Google Scholar
• Wahab Khan M, Jahangir Alam M, Rashid MA, et al. A new structural alternative in benzo[b]furans for antimicrobial activity. Bioorg Med Chem 2005;13:4796–805.
   PubMed Web of Science ®Google Scholar
• Manna K, Agrawal YK. Design, synthesis, and antitubercular evaluation of novel series of 3-benzofuran-5-aryl-1-pyrazolyl-pyridylmethanone and 3-benzofuran-5-aryl-1-pyrazolylcarbonyl-4-oxo-naphthyridin analogs. Euro J Med Chem 2010;45:3831–9.
   PubMed Web of Science ®Google Scholar
• Peschke B, Bak S, Hohlweg R, et al. Benzo[b]thiophene-2-carboxamides and benzo[b]furan-2-carboxamides are potent antagonists of the human h3-receptor. Bioorg Med Chem Lett 2006;16:3162–5.
   PubMed Web of Science ®Google Scholar
• Wang XD, Deng RC, Dong JJ, et al. 3-aryl-4-acyloxyethoxyfuran-2(5h)-ones as inhibitors of tyrosyl-trna synthetase: synthesis, molecular docking and antibacterial evaluation. Bioorg Med Chem 2013;21:4914–22.
   PubMed Web of Science ®Google Scholar
• Wang XD, Wei W, Wang PF, et al. Novel 3-arylfuran-2(5h)-one-fluoroquinolone hybrid: design, synthesis and evaluation as antibacterial agent. Bioorg Med Chem 2014;22:3620–8.
   PubMed Web of Science ®Google Scholar
• Wei W, Shi WK, Wang PF, et al. Adenosine analogs as inhibitors of tyrosyl-trna synthetase: design, synthesis and antibacterial evaluation. Bioorg Med Chem 2015;23:6602–11.
   PubMed Web of Science ®Google Scholar
• Mphahlele MJ, Maluleka MM, Parbhoo N, et al. Synthesis, evaluation for cytotoxicity and molecular docking studies of benzo[c]furan-chalcones for potential to inhibit tubulin polymerization and/or egfr-tyrosine kinase phosphorylation. Inter J Mol Sci 2018;19:2552.
   PubMed Web of Science ®Google Scholar
• Sravanthi TV, Manju SL. Indoles – a promising scaffold for drug development. Eur J Pharm Sci 2016;91:1–10.
   PubMed Web of Science ®Google Scholar
• Singh TP, Singh OM. Recent progress in biological activities of indole and indole alkaloids. Mini Rev Med Chem2018;18:9–25.
   PubMed Web of Science ®Google Scholar
• Gil-Turnes MS, Hay ME, Fenical W. Symbiotic marine bacteria chemically defend crustacean embryos from a pathogenic fungus. Science 1989;246:116–8.
   PubMed Web of Science ®Google Scholar
• Sivakumar PM, Kumar TM, Doble M. Antifungal activity, mechanism and qsar studies on chalcones. Chem Biol Drug Des 2009;74:68–79.
   PubMed Web of Science ®Google Scholar
• Hashemi SM, Badali H, Faramarzi MA, et al. Novel triazole alcohol antifungals derived from fluconazole: design, synthesis, and biological activity. Mol Divers 2015;19:15–27.
   PubMed Web of Science ®Google Scholar
• Aryapour H, Riazi GH, Ahmadian S, et al. Induction of apoptosis through tubulin inhibition in human cancer cells by new chromene-based chalcones. Pharm Biol 2012;50:1551–60.
   PubMed Web of Science ®Google Scholar
• Mirzaei H, Abastabar M, Emami S. Indole-derived chalcones as anti-dermatophyte agents: in vitro evaluation and in silico study. Comput Biol Chem 2020;84:107189.
   PubMed Web of Science ®Google Scholar
• Boumendjel A, McLeer-Florin A, Champelovier P, et al. A novel chalcone derivative which acts as a microtubule depolymerising agent and an inhibitor of p-gp and bcrp in in-vitro and in-vivo glioblastoma models. BMC Cancer 2009;9:242.
   PubMed Web of Science ®Google Scholar
• Martel-Frachet V, Keramidas M, Nurisso A, et al. Ipp51, a chalcone acting as a microtubule inhibitor with in vivo antitumor activity against bladder carcinoma. Oncotarget 2015;6:14669–86.
   PubMedGoogle Scholar
• Mirzaei H, Shokrzadeh M, Modanloo M, et al. New indole-based chalconoids as tubulin-targeting antiproliferative agents. Bioorg Chem 2017;75:86–98.
   PubMed Web of Science ®Google Scholar
• Preti D, Romagnoli R, Rondanin R, et al. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach. J Enzyme Inhib Med Chem 2018;33:1225–38.
   PubMed Web of Science ®Google Scholar
• Lokwani P, Nagori B, Batra N, et al. Benzoxazole: the molecule of diverse biological activities. J Chem Pharma Res 2011;3:302–11.
   Google Scholar
• Paramashivappa R, Phani Kumar P, Subba Rao PV, et al. Design, synthesis and biological evaluation of benzimidazole/benzothiazole and benzoxazole derivatives as cyclooxygenase inhibitors. Bioorg Med Chem Letters 2003;13:657–60.
   PubMed Web of Science ®Google Scholar
• Hall IH, Peaty NJ, Henry JR, et al. Investigations on the mechanism of action of the novel antitumor agents 2-benzothiazolyl, 2-benzoxazolyl, and 2-benzimidazolyl hydrazones derived from 2-acetylpyridine. Arch Pharm 1999;332:115–23.
   PubMed Web of Science ®Google Scholar
• Saari WS, Wai JS, Fisher TE, et al. Synthesis and evaluation of 2-pyridinone derivatives as hiv-1-specific reverse transcriptase inhibitors. 2. Analogues of 3-aminopyridin-2(1h)-one. J Med Chem 1992;35:3792–802.
   PubMed Web of Science ®Google Scholar
• Temiz-Arpaci O, Aki-Sener E, Yalcin I, et al. Cheminform abstract: synthesis and antimicrobial activity of some 2-[p-substituted-phenyl]benzoxazol-5-yl-arylcarboxyamides. Cheminform 2010;33:49.
   Google Scholar
• Modiya PR, Patel CN. Synthesis and screening of antibacterial and antifungal activity of 5-chloro-1,3-benzoxazol-2(3 h)-one derivatives. Org Med Chem Lett 2012;2:29.
   PubMedGoogle Scholar
• Nargund LV, Reddy GR, Hariprasad V. Anti-inflammatory activity of substituted 1,3,4-oxadiazoles. J Pharm Sci 1994;83:246–8.
   PubMed Web of Science ®Google Scholar
• Konieczny MT, Buɬakowska A, Pirska D, et al. Structural factors affecting affinity of cytotoxic oxathiole-fused chalcones toward tubulin. Euro J Med Chem 2015;89:733–42.
   PubMed Web of Science ®Google Scholar
• Konieczny MT, Buɬakowska A, Pirska D, et al. Influence of s-oxidation on cytotoxic activity of oxathiole-fused chalcones. Chem Biol Drug Design 2016;88:519–33.
   PubMed Web of Science ®Google Scholar
• Kumar S, Bawa S, Gupta H. Biological activities of quinoline derivatives. Mini Rev Med Chem 2009;9:1648–54.
   PubMed Web of Science ®Google Scholar
• Xiao ZP, Wang XD, Wang PF, et al. Design, synthesis, and evaluation of novel fluoroquinolone-flavonoid hybrids as potent antibiotics against drug-resistant microorganisms. Eur J Med Chem 2014;80:92–100.
   PubMed Web of Science ®Google Scholar
• Solomon VR, Lee H. Quinoline as a privileged scaffold in cancer drug discovery. Curr Med Chem 2011;18:1488–508.
   PubMed Web of Science ®Google Scholar
• Chokkar N, Kalra S, Chauhan M, et al. A review on quinoline derived scaffolds as anti-hiv agents. Mini Rev Med Chem2019;19:510–26.
   PubMed Web of Science ®Google Scholar
• Mirzaei S, Hadizadeh F, Eisvand F, et al. Synthesis, structure-activity relationship and molecular docking studies of novel quinoline-chalcone hybrids as potential anticancer agents and tubulin inhibitors. J Mol Struc 2020;1202:127310.
   Web of Science ®Google Scholar
• Lindamulage IK, Vu HY, Karthikeyan C, et al. Novel quinolone chalcones targeting colchicine-binding pocket kill multidrug-resistant cancer cells by inhibiting tubulin activity and mrp1 function. Sci Rep 2017;7:10298.
   PubMed Web of Science ®Google Scholar
• Tseng CH, Tzeng CC, Hsu CY, et al. Discovery of 3-phenylquinolinylchalcone derivatives as potent and selective anticancer agents against breast cancers. Euro J Med Chem 2015;97:306–19.
   PubMed Web of Science ®Google Scholar
• Rahimzadeh Oskuei S, Mirzaei S, Reza Jafari-Nik M, et al. Design, synthesis and biological evaluation of novel imidazole-chalcone derivatives as potential anticancer agents and tubulin polymerization inhibitors. Bioorg Chem 2021;112:104904.
   PubMed Web of Science ®Google Scholar
• Sultana F, Reddy Bonam S, Reddy VG, et al. Synthesis of benzo[d]imidazo[2,1-b]thiazole-chalcone conjugates as microtubule targeting and apoptosis inducing agents. Bioorg Chem 2018;76:1–12.
   PubMed Web of Science ®Google Scholar
• Rathnakar B, Kumar GS, Mahammad SP, et al. Design, synthesis, and evaluation of novel combretastatin a‐4 based chalcone derivatives as anticancer agents. J Heterocyclic Chem 2021;58:488–501.
   Web of Science ®Google Scholar
• Romagnoli R, Baraldi PG, Carrion MD, et al. Design, synthesis, and biological evaluation of thiophene analogues of chalcones. Bioorg Med Chem 2008;16:5367–76.
   PubMed Web of Science ®Google Scholar
• Wang Q, Arnst KE, Wang Y, et al. Structural modification of the 3,4,5-trimethoxyphenyl moiety in the tubulin inhibitor veru-111 leads to improved antiproliferative activities. J Med Chem 2018;61:7877–91.
   PubMed Web of Science ®Google Scholar
• Han H, Zhao Y, Cuthbertson T, et al. Cell cycle arrest and apoptosis induction by an anticancer chalcone epoxide. Arch Pharm 2010;343:429–39.
   PubMed Web of Science ®Google Scholar
• Berlinck RGS, Trindade-Silva AE, Santos MFC. The chemistry and biology of organic guanidine derivatives. Nat Prod Rep 2012;29:1382–406.
   PubMed Web of Science ®Google Scholar
• Kim SH, Semenya D, Castagnolo D. Antimicrobial drugs bearing guanidine moieties: a review. Eur J Med Chem 2021;216:113293.
   PubMed Web of Science ®Google Scholar
• Kim JS, Lee J, Chung HW, et al. Methylglyoxal-bis(guanylhydrazone), a polyamine analogue, sensitized γ-radiation-induced cell death in HL-60 leukemia cells Sensitizing effect of MGBG on γ-radiation-induced cell death. Environ Toxicol Pharmacol 2006;22:160–6.
   PubMed Web of Science ®Google Scholar
• Qian Y, Zhang HJ, Lv PC, et al. Synthesis, molecular modeling and biological evaluation of guanidine derivatives as novel antitubulin agents. Bioorg Med Chem 2010;18:8218–25.
   PubMed Web of Science ®Google Scholar
• Wang Y-T, Qin Y-J, Zhang Y-L, et al. Synthesis, biological evaluation, and molecular docking studies of novel chalcone oxime derivatives as potential tubulin polymerization inhibitors. RSC Adv 2014;4:32263–75.
   Web of Science ®Google Scholar
• Peyrot V, Leynadier D, Sarrazin M, et al. Interaction of tubulin and cellular microtubules with the new antitumor drug mdl 27048. J Biol Chem 1989;264:21296–301.
   PubMed Web of Science ®Google Scholar
• Peyrot V, Leynadier D, Sarrazin M, et al. Mechanism of binding of the new antimitotic drug mdl 27048 to the colchicine site of tubulin: equilibrium studies. Biochemistry 1992;31:11125–32.
   PubMed Web of Science ®Google Scholar
• Lawrence NJ, Patterson RP, Ooi LL, et al. Effects of alpha-substitutions on structure and biological activity of anticancer chalcones. Bioorg Med Chem Lett 2006;16:5844–8.
   PubMed Web of Science ®Google Scholar
• Kerr DJ, Hamel E, Jung MK, et al. The concise synthesis of chalcone, indanone and indenone analogues of combretastatin a4. Bioorg Med Chem 2007;15:3290–8.
   PubMed Web of Science ®Google Scholar
• Ducki S, Rennison D, Woo M, et al. Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: synthesis and biological evaluation of antivascular activity. Bioorg Med Chem 2009;17:7698–710.
   PubMed Web of Science ®Google Scholar
• Ducki S, Mackenzie G, Greedy B, et al. Combretastatin-like chalcones as inhibitors of microtubule polymerisation. Part 2: structure-based discovery of alpha-aryl chalcones. Bioorg Med Chem 2009;17:7711–22.
   PubMed Web of Science ®Google Scholar
• Yan J, Chen J, Zhang S, et al. Synthesis, evaluation, and mechanism study of novel indole-chalcone derivatives exerting effective antitumor activity through microtubule destabilization in vitro and in vivo. J Med Chem 2016;59:5264–83.
   PubMed Web of Science ®Google Scholar
• Li W, Xu F, Shuai W, et al. Discovery of novel quinoline-chalcone derivatives as potent antitumor agents with microtubule polymerization inhibitory activity. J Med Chem 2019;62:993–1013.
   PubMed Web of Science ®Google Scholar
• Xu F, Li W, Shuai W, et al. Design, synthesis and biological evaluation of pyridine-chalcone derivatives as novel microtubule-destabilizing agents. Euro J Med Chem 2019;173:1–14.
   PubMed Web of Science ®Google Scholar
• Cong H, Zhao X, Castle BT, et al. An indole-chalcone inhibits multidrug-resistant cancer cell growth by targeting microtubules. Mol Pharm 2018;15:3892–900.
   PubMedGoogle Scholar
• Canela M-D, Noppen S, Bueno O, et al. Antivascular and antitumor properties of the tubulin-binding chalcone tub091. Oncotarget 2017;8:14325–42.
   PubMedGoogle Scholar
• Berube G. An overview of molecular hybrids in drug discovery. Exp Opin Drug Disc 2016;11:281–305.
   PubMed Web of Science ®Google Scholar
• Shaveta Mishra S, Singh P. Hybrid molecules: the privileged scaffolds for various pharmaceuticals. Eur J Med Chem 2016;124:500–36.
   PubMed Web of Science ®Google Scholar
• Ivasiv V, Albertini C, Goncalves AE, et al. Molecular hybridization as a tool for designing multitarget drug candidates for complex diseases. Curr Top Med Chem 2019;19:1694–711.
   PubMed Web of Science ®Google Scholar
• Gibson D. Platinum(iv) anticancer agents; are we en route to the holy grail or to a dead end? J Inorg Biochem 2021;217:111353.
   PubMed Web of Science ®Google Scholar
• Schobert R, Biersack B, Dietrich A, et al. Pt(ii) complexes of a combretastatin a-4 analogous chalcone: effects of conjugation on cytotoxicity, tumor specificity, and long-term tumor growth suppression. J Med Chem 2009;52:241–6.
   PubMed Web of Science ®Google Scholar
• Zoldakova M, Kornyei Z, Brown A, et al. Effects of a combretastatin a4 analogous chalcone and its pt-complex on cancer cells: a comparative study of uptake, cell cycle and damage to cellular compartments. Biochem Pharmacol 2010;80:1487–96.
   PubMed Web of Science ®Google Scholar
• Huang X, Huang R, Wang Z, et al. Pt(iv) complexes conjugating with chalcone analogue as inhibitors of microtubule polymerization exhibited selective inhibition in human cancer cells. Euro J Med Chem 2018;146:435–50.
   PubMed Web of Science ®Google Scholar
• Huang X, Hua S, Huang R, et al. Dual-targeting antitumor hybrids derived from pt(iv) species and millepachine analogues. Euro J Med Chem 2018;148:1–25.
   PubMed Web of Science ®Google Scholar
• Huang X, Liu Z, Wang M, et al. Platinum(iv) complexes conjugated with chalcone analogs as dual targeting anticancer agents: in vitro and in vivo studies. Bioorg Chem 2020;105:104430.
   PubMed Web of Science ®Google Scholar
• Diethelm-Varela B, Ai Y, Liang DD, et al. Nitrogen mustards as anticancer chemotherapies: HISTORIC perspective, current developments and future trends. Curr Top Med Chem 2019;19:691–712.
   PubMed Web of Science ®Google Scholar
• More GS, Thomas AB, Chitlange SS, et al. Nitrogen mustards as alkylating agents: a review on chemistry, mechanism of action and current usfda status of drugs. Anticancer Agents Med Chem 2019;19:1080–102.
   PubMed Web of Science ®Google Scholar
• Chen YM, Jia YP, Song WG, et al. Therapeutic potential of nitrogen mustard based hybrid molecules. Front Pharmacol 2018;9:1453.
   PubMed Web of Science ®Google Scholar
• Sabina XJ, Karthikeyan J, Velmurugan G, et al. Design and in vitro biological evaluation of substituted chalcones synthesized from nitrogen mustards as potent microtubule targeted anticancer agents. New Journal of Chemistry 2017;41:4096–109.
   Web of Science ®Google Scholar
• Sharma PC, Sinhmar A, Sharma A, et al. Medicinal significance of benzothiazole scaffold: an insight view. J Enzyme Inhib Med Chem 2013;28:240–66.
   PubMed Web of Science ®Google Scholar
• Keri RS, Patil MR, Patil SA, et al. A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry. Eur J Med Chem 2015;89:207–51.
   PubMed Web of Science ®Google Scholar
• Rouf A, Tanyeli C. Bioactive thiazole and benzothiazole derivatives. Eur J Med Chem 2015;97:911–27.
   PubMed Web of Science ®Google Scholar
• Mohamed LW, Taher AT, Rady GS, et al. Synthesis and cytotoxic activity of certain benzothiazole derivatives against human mcf-7 cancer cell line. Chem Biol Drug Design 2017;89:566–76.
   PubMed Web of Science ®Google Scholar
• Kharbanda C, Alam MS, Hamid H, et al. Synthesis and evaluation of pyrazolines bearing benzothiazole as anti-inflammatory agents. Bioorg Med Chem 2014;22:5804–12.
   PubMed Web of Science ®Google Scholar
• Uremis N, Uremis MM, Tolun FI, et al. Synthesis of 2-substituted benzothiazole derivatives and their in vitro anticancer effects and antioxidant activities against pancreatic cancer cells. Anticancer Res 2017;37:6381–9.
   PubMed Web of Science ®Google Scholar
• Soni B, Ranawat MS, Sharma R, et al. Synthesis and evaluation of some new benzothiazole derivatives as potential antimicrobial agents. Euro J Med Chem 2010;45:2938–42.
   PubMed Web of Science ®Google Scholar
• De SK, Chen LH, Stebbins JL, et al. Discovery of 2-(5-nitrothiazol-2-ylthio)benzo[d]thiazoles as novel c-jun n-terminal kinase inhibitors. Bioorg Med Chem 2009;17:2712–7.
   PubMedGoogle Scholar
• Kamal A, Mallareddy A, Suresh P, et al. Synthesis of chalcone-amidobenzothiazole conjugates as antimitotic and apoptotic inducing agents. Bioorg Med Chem 2012;20:3480–92.
   PubMed Web of Science ®Google Scholar
• Maddila S, Pagadala R, Jonnalagadda SB. 1,2,4-triazoles: a review of synthetic approaches and the biological activity. Lett Org Chem 2013;10:693–714.
   Web of Science ®Google Scholar
• Sathyanarayana R, Poojary B. Exploring recent developments on 1,2,4-triazole: synthesis and biological applications. J Chin Chem Soc 2020;67:459–77.
   Web of Science ®Google Scholar
• Shibasaki M, Fujimori A, Kusayama T, et al. Antihypertensive activity of a nonpeptide angiotensin ii receptor antagonist, ym358, in rats and dogs. Eur J Pharmacol 1997;335:175–84.
   PubMed Web of Science ®Google Scholar
• Mizuno M, Inagaki A, Yamashita M, et al. Process development of a disease-modifying antirheumatic drug, tak-603, based on optimization of friedel–crafts reaction and selective substitution of a triazole ring. Tetrahedron 2006;62:4065–70.
   Web of Science ®Google Scholar
• Aiken SP, Brown WM. Treatment of epilepsy: existing therapies and future developments. Front Biosci 2000;5:E124–52.
   PubMed Web of Science ®Google Scholar
• Grana G. Adjuvant aromatase inhibitor therapy for early breast cancer: a review of the most recent data. J Surg Oncol 2006;93:585–92.
   PubMed Web of Science ®Google Scholar
• Alswah M, Bayoumi AH, Elgamal K, et al. Design, synthesis and cytotoxic evaluation of novel chalcone derivatives bearing triazolo[4,3-a]-quinoxaline moieties as potent anticancer agents with dual egfr kinase and tubulin polymerization inhibitory effects. Molecules 2017;23:48.
   PubMed Web of Science ®Google Scholar
• Zhang H, Liu JJ, Sun J, et al. Design, synthesis and biological evaluation of novel chalcone derivatives as antitubulin agents. Bioorg Med Chem 2012;20:3212–8.
   PubMed Web of Science ®Google Scholar
• Pitsinos EN, Vidali VP, Couladouros EA. Diaryl ether formation in the synthesis of natural products. Euro J Organic Chem 2011;2011:1207–22.
   Web of Science ®Google Scholar
• Bedos-Belval F, Rouch A, Vanucci-Bacque C, et al. Diaryl ether derivatives as anticancer agents – a review. Med Chem Comm 2012;3:1356–72.
   Web of Science ®Google Scholar
• Zhao T-T, Lu X, Yang X-H, et al. Synthesis, biological evaluation, and molecular docking studies of 2,6-dinitro-4-(trifluoromethyl)phenoxysalicylaldoxime derivatives as novel antitubulin agents. Bioorg Med Chem 2012;20:3233–41.
   PubMed Web of Science ®Google Scholar
• Wang W, Kong D, Cheng H, et al. New benzimidazole-2-urea derivates as tubulin inhibitors. Bioorg Med Chem Lett 2014;24:4250–3.
   PubMed Web of Science ®Google Scholar
• Bai L-F, Qian H-H, Jiang D-W, et al. Design, synthesis and anti-tubulin activity of novel dinitro diphenyl ether derivatives as potent anticancer agent. Med Chem 2017;7:393–7.
   Google Scholar
• Wang G, Liu W, Gong Z, et al. Design, synthesis, biological evaluation and molecular docking studies of new chalcone derivatives containing diaryl ether moiety as potential anticancer agents and tubulin polymerization inhibitors. Bioorg Chem 2020;95:103565.
   PubMed Web of Science ®Google Scholar
• Qiu HY, Wang F, Wang X, et al. Design, synthesis, and biological evaluation of chalcone-containing shikonin derivatives as inhibitors of tubulin polymerization. Chem Med Chem 2017;12:399–406.
   Google Scholar
• Shankaraiah N, Nekkanti S, Brahma UR, et al. Synthesis of different heterocycles-linked chalcone conjugates as cytotoxic agents and tubulin polymerization inhibitors. Bioorg Med Chem 2017;25:4805–16.
   PubMed Web of Science ®Google Scholar
• Huang X, Huang R, Li L, et al. Synthesis and biological evaluation of novel chalcone derivatives as a new class of microtubule destabilizing agents. Euro J Med Chem 2017;132:11–25.
   PubMed Web of Science ®Google Scholar
• Kumar D, Raj KK, Malhotra SV, et al. Synthesis and anticancer activity evaluation of resveratrol–chalcone conjugates. Med Chem Comm 2014;5:528–35.
   Google Scholar
• Kamal A, Kumar GB, Vishnuvardhan MV, et al. Synthesis of phenstatin/isocombretastatin-chalcone conjugates as potent tubulin polymerization inhibitors and mitochondrial apoptotic inducers. Org Biomol Chem 2015;13:3963–81.
   PubMed Web of Science ®Google Scholar
• Kode J, Kovvuri J, Nagaraju B, et al. Synthesis, biological evaluation, and molecular docking analysis of phenstatin based indole linked chalcones as anticancer agents and tubulin polymerization inhibitors. Bioorg Chem 2020;105:104447.
   PubMed Web of Science ®Google Scholar
• Mourad AAE, Mourad MAE, Jones PG. Novel hdac/tubulin dual inhibitor: design, synthesis and docking studies of α-Phthalimido-Chalcone Hybrids as Potential Anticancer Agents with Apoptosis-Inducing Activity. Drug Des Devel Ther 2020;14:3111–30.
   PubMed Web of Science ®Google Scholar